Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083

By afschroeder • April 28, 2026

Landovitz RJ, Fogel JM, Gao F, Hanscom B, Piwowar-Manning E, Moser A, Marzinke MA, Cyktor J, Seisa M, Halvas EK, Kofron R, Jennings A, Clement M, Viet Tran H, Gaur A, Fichtenbaum CJ, Asmelash A, Soto-Torres L, Rooney JF, Rinehart AR, Cohen MS, Grinsztejn B, Eshleman SH. Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083. Clin Infect Dis. 2026 Apr 27:ciag285. doi: 10.1093/cid/ciag285. Epub ahead of print. PMID: 42044061.

Tags: Cabotegravir, Diagnosis, HIV, Infectious Diseases, injectable, Pre-exposure prophylaxis, Publications, RNA

DASC-LOT Framework and S3 Metric: A Novel Evaluation and Benchmarking Method to Assess Initiation, Duration, and Spectrum of Antimicrobial Usage at Inpatient Hospital Settings

Goto M, Imai S, Cho H, Merchant JA, Goetz MB, Perencevich EN, Alexander B, Shi Q, Holcombe A, Livorsi DJ. DASC-LOT Framework and S3 Metric:[...]

Intent to Accept a Valley Fever Vaccine for Humans and Dogs and Factors Influencing Intended Uptake: A Cross-Sectional Survey in Two Endemic Regions

Hermann JN, Kruger SE, Wodniak N, Holland J, Janosick V, Sanchez A, Zuniga-Moya JC, Brucker D, Torres B, Melo KM, Oliveros E, Kuran R, D'Assumpcao[...]

Structure and potential role of T6SS effector PdpC in Francisella tularensis intracellular lifestyle

Liu X, Clemens DL, Lee BY, Xia X, Fan H, Feng KY, Horwitz MA, Zhou ZH. Structure and potential role of T6SS effector PdpC in[...]